TriSalus Life Sciences, Inc. (TLSI) Stock Overview
Explore TriSalus Life Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
TriSalus Life Sciences, Inc. (TLSI)
Key Financials
Key Financials
Market Cap
160M
P/E Ratio
-3.02
EPS (TTM)
$-1.68
ROE
1.63%
TLSI Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of TriSalus Life Sciences, Inc. (NASDAQ: TLSI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, TriSalus Life Sciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of TLSI on the NASDAQ shows an RSI of 52.65, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.25 for the NASDAQ listing.
Key metrics behind TriSalus Life Sciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -3.02 and a market capitalization of 160M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TLSI on the NASDAQ.